APT(SH:688617)2025-02-24 11:20Financial Performance - Total operating revenue for 2024 reached CNY 2,065.80 million, a 25.18% increase compared to the previous year[3] - Net profit attributable to shareholders of the parent company was CNY 673.48 million, up 26.14% year-on-year[3] - Net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses increased by 37.36% to CNY 643.33 million[3] - Basic earnings per share rose to CNY 6.96, representing a 25.63% increase[3] Assets and Equity - Total assets at the end of the reporting period amounted to CNY 2,975.72 million, reflecting a 15.65% growth from the beginning of the period[3] - Shareholders' equity attributable to the parent company increased by 31.68% to CNY 2,511.36 million[3] - The increase in shareholders' equity and net asset value per share was primarily driven by profit growth[7] Market Expansion - The company expanded its market presence through various promotional activities and enhanced product coverage and hospital admission rates[5] - The company actively pursued international market expansion, increasing investment in overseas business[5] Capital Management - The company implemented a capital reserve conversion to increase its share capital by 45.67% during the reporting period[7]